HIGHLIGHTS
- who: Chenghui Zhou from the CEA Normal have published the article: The effects of chemotherapy, primary tumor location and histological subtype on the survival of stage III colon cancer patients, in the Journal: (JOURNAL)
- what: This study found survival differences in the subgroups of stage III CC, and chemotherapy, LCC or AC was associated with improved OS.
- how: The results showed that chemotherapy left-sided CC (LCC) and AC were favorable prognostic factors for OS. The results showed that the OS of the nonchemotherapy group was poorer than that of the chemotherapy group . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.